Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Control of viral infections by epigenetic-targeted therapy.

Nehme Z, Pasquereau S, Herbein G.

Clin Epigenetics. 2019 Mar 27;11(1):55. doi: 10.1186/s13148-019-0654-9. Review.

2.

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH.

J Neurovirol. 2019 Mar 13. doi: 10.1007/s13365-019-00732-3. [Epub ahead of print]

PMID:
30868421
3.

Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study.

Faivre M, Cottet V, Bour JB, Richou C, Valmary-Degano S, Thiefin G, Andreoletti L, Geist C, Schvoerer E, Malvé B, Habersetzer F, Fafi-Kremer S, Binquet C, Jouve JL, Bronowicki JP, Doffoel M, Hillon P, Herbein G, Monnet E, Di Martino V; CirCE Study Group.

J Clin Gastroenterol. 2019 Mar;53(3):236-241. doi: 10.1097/MCG.0000000000001039.

PMID:
30383568
4.

The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits.

Moussawi FA, Kumar A, Pasquereau S, Tripathy MK, Karam W, Diab-Assaf M, Herbein G.

Sci Rep. 2018 Aug 22;8(1):12574. doi: 10.1038/s41598-018-30109-1.

5.

The Human Cytomegalovirus, from Oncomodulation to Oncogenesis.

Herbein G.

Viruses. 2018 Aug 3;10(8). pii: E408. doi: 10.3390/v10080408. Review.

6.

Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages.

Pasquereau S, Kumar A, Abbas W, Herbein G.

Viruses. 2018 Apr 13;10(4). pii: E190. doi: 10.3390/v10040190.

7.

The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.

Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S, Adotevi O, Morot-Bizot S, Herbein G.

EBioMedicine. 2018 Apr;30:167-183. doi: 10.1016/j.ebiom.2018.03.015. Epub 2018 Mar 28.

8.

Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.

Pasquereau S, Kumar A, Herbein G.

Viruses. 2017 Mar 30;9(4). pii: E64. doi: 10.3390/v9040064. Review.

9.

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

Kumar A, Abbas W, Bouchat S, Gatot JS, Pasquereau S, Kabeya K, Clumeck N, De Wit S, Van Lint C, Herbein G.

Sci Rep. 2016 Dec 6;6:38313. doi: 10.1038/srep38313.

10.

Cellular Senescence, Immunosenescence and HIV.

Fülöp T, Herbein G, Cossarizza A, Witkowski JM, Frost E, Dupuis G, Pawelec G, Larbi A.

Interdiscip Top Gerontol Geriatr. 2017;42:28-46. Epub 2016 Nov 22. Review.

PMID:
27875822
11.

TNF and HIV-1 Nef: An Intimate Interplay.

Herbein G.

EBioMedicine. 2016 Nov;13:25-26. doi: 10.1016/j.ebiom.2016.11.009. Epub 2016 Nov 9. No abstract available.

12.

Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.

Kumar A, Coquard L, Pasquereau S, Russo L, Valmary-Degano S, Borg C, Pothier P, Herbein G.

Mol Ther Oncolytics. 2016 Apr 27;3:16012. doi: 10.1038/mto.2016.12. eCollection 2016.

13.

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.

Kumar A, Abbas W, Colin L, Khan KA, Bouchat S, Varin A, Larbi A, Gatot JS, Kabeya K, Vanhulle C, Delacourt N, Pasquereau S, Coquard L, Borch A, König R, Clumeck N, De Wit S, Rohr O, Rouzioux C, Fulop T, Van Lint C, Herbein G.

Sci Rep. 2016 Apr 14;6:24090. doi: 10.1038/srep24090.

14.

Effect of ZIP2 Gln/Arg/Leu (rs2234632) polymorphism on zinc homeostasis and inflammatory response following zinc supplementation.

Giacconi R, Costarelli L, Malavolta M, Cardelli M, Galeazzi R, Piacenza F, Gasparini N, Basso A, Mariani E, Fulop T, Rink L, Dedoussis G, Herbein G, Jajte J, Provinciali M, Busco F, Mocchegiani E.

Biofactors. 2015 Nov-Dec;41(6):414-23. doi: 10.1002/biof.1247. Epub 2015 Dec 8.

PMID:
26643924
15.

Epigenetic control of HIV-1 post integration latency: implications for therapy.

Kumar A, Darcis G, Van Lint C, Herbein G.

Clin Epigenetics. 2015 Sep 24;7:103. doi: 10.1186/s13148-015-0137-6. eCollection 2015. Review.

16.

The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis.

Gamonet C, Deschamps M, Marion S, Herbein G, Chiocchia G, Auger I, Saas P, Ferrand C, Toussirot E.

Rheumatology (Oxford). 2015 Sep;54(9):1744-5. doi: 10.1093/rheumatology/kev210. Epub 2015 Jun 27. No abstract available.

PMID:
26117335
17.

Targeting TNF-Alpha in HIV-1 Infection.

Kumar A, Coquard L, Herbein G.

Curr Drug Targets. 2016;17(1):15-22. Review.

PMID:
26073859
18.

The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections.

Abbas W, Kumar A, Herbein G.

Front Oncol. 2015 Apr 7;5:75. doi: 10.3389/fonc.2015.00075. eCollection 2015. Review.

19.

Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?

Abbas W, Tariq M, Iqbal M, Kumar A, Herbein G.

Viruses. 2015 Mar 31;7(4):1578-98. doi: 10.3390/v7041578. Review.

20.

Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis.

Wendling D, Abbas W, Godfrin-Valnet M, Kumar A, Guillot X, Khan KA, Vidon C, Coquard L, Toussirot E, Prati C, Herbein G.

PLoS One. 2015 Mar 23;10(3):e0119981. doi: 10.1371/journal.pone.0119981. eCollection 2015.

Supplemental Content

Loading ...
Support Center